申请人:Knoll Aktiengesellschaft
公开号:US05905079A1
公开(公告)日:1999-05-18
Certain 1,2,4-triazolo(4,3-b)pyridazines of formula ##STR1## including pharmaceutically acceptable salts thereof, wherein R.sub.1 -R.sub.8 are as defined in the disclosure, for the treatment, prophylaxis and/or inhibition of seizures, neurological disorders such as epilepsy and/or conditions in which there is neurological damage such as stroke, brain trauma, cerebral ischemia, head injuries and hemorrhage are disclosed.
某些1,2,4-三唑并(4,3-b)吡啶嘧啶的化学式如下:##STR1## 包括其药用可接受的盐,其中R.sub.1 -R.sub.8如披露中定义,用于治疗、预防和/或抑制癫痫发作、神经系统疾病如癫痫以及神经损伤如中风、脑外伤、脑缺血、头部受伤和出血等病症。